Caris Life Sciences Introduces MET IHC Testing for Lung Cancer Treatment Standardization Caris Life Sciences sets a new standard for treating non-squamous non-small cell lung cancer with its MET Immunohistochemistry testing, enhancing personalized medicine.

Caris Life Sciences Introduces MET IHC Testing for Lung Cancer Treatment Standardization #United_States #Caris_Life_Sciences #Irving,_Texas #Cancer_Biomarkers #MET_IHC